You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PF-06863135

Showing 1 - 25 of 1,087
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed or Refractory Multiple Myeloma Trial in Nagoya, Shibuya-ku (Elranatamab (PF-06863135))

Active, not recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Elranatamab (PF-06863135)
  • Nagoya, Aichi, Japan
  • +1 more
Jun 20, 2022

Elranatamab, Myeloma, Multiple Myeloma Trial in China (Elranatamab)

Recruiting
  • Elranatamab
  • +10 more
  • Fuzhou, Fujian, China
  • +18 more
Jan 18, 2023

Multiple Myeloma Trial (Elranatamab)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Aug 28, 2023

Medicine Called Elranatamab in People With Relapsed Refractory

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jun 30, 2023

Multiple Myeloma Trial (Elranatamab (PF-06863135))

Temporarily not available
  • Multiple Myeloma
  • Elranatamab (PF-06863135)
  • (no location specified)
Jul 15, 2022

Multiple Myeloma Trial (Elranatamab)

Available
  • Multiple Myeloma
  • (no location specified)
Feb 3, 2022

Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Nagaizumi-cho,Sunto-gun, Shizuoka, Japan
  • +7 more
Jan 9, 2023

Learn About Medicine in People With Relapsed Refractory Multiple

Completed
  • Multiple Myeloma
  • New York, New York
    Pfizer
Nov 14, 2022

Multiple Myeloma Trial in Canada, United States (PF-06863135 monotherapy IV or SC, PF-06863135 + dexamethasone, PF-06863135 +

Active, not recruiting
  • Multiple Myeloma
  • PF-06863135 monotherapy IV or SC
  • +3 more
  • Encinitas, California
  • +37 more
Jul 7, 2022

Multiple Myeloma Trial in Beverly Hills (Elranatamab, Carfilzomib)

Recruiting
  • Multiple Myeloma
  • Beverly Hills, California
    Beverly Hills Cancer Center
Dec 21, 2022

Multiple Myeloma Trial in Worldwide (Elranatamab (PF-06863135))

Active, not recruiting
  • Multiple Myeloma
  • Elranatamab (PF-06863135)
  • Beverly Hills, California
  • +75 more
Oct 4, 2022

Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Pomalidomide)

Recruiting
  • Multiple Myeloma
  • Woolloongabba, Queensland, Australia
  • +117 more
Aug 3, 2022

Multiple Myeloma Trial in Worldwide (Elranatamab)

Recruiting
  • Multiple Myeloma
  • Fort Collins, Colorado
  • +33 more
Aug 17, 2022

Multiple Myeloma Trial (Elranatamab, Elotuzumab, Pomalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Nov 28, 2023

Multiple Myeloma Trial in Worldwide (Elranatamab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Benowa, Queensland, Australia
  • +132 more
Jan 24, 2023

Healthy Participants Trial (Single dose of PF-07220060 as first Tablet Formulation, Single dose of PF-07220060 as second Tablet

Not yet recruiting
  • Healthy Participants
  • Single dose of PF-07220060 as first Tablet Formulation
  • +3 more
  • (no location specified)
Jun 20, 2023

Atopic Dermatitis Trial in United States (PF-07275315, PF-07264660, Placebo)

Not yet recruiting
  • Atopic Dermatitis
  • Huntington Beach, California
  • +3 more
Aug 21, 2023

Healthy Trial (PF-07976016, Placebo, Midazolam)

Not yet recruiting
  • Healthy
  • (no location specified)
Oct 24, 2023

Healthy Trial in New Haven, Brussels (PF-07817883, Placebo, Midazolam)

Recruiting
  • Healthy
  • New Haven, Connecticut
  • +1 more
Dec 19, 2022

Hemiparesis;Poststroke/CVA Trial in Créteil (Eccentric training, Conventional therapy)

Recruiting
  • Hemiparesis;Poststroke/CVA
  • Eccentric training
  • Conventional therapy
  • Créteil, France
    Wael Maktouf
Nov 16, 2023

Pulmonary Arterial Hypertension Trial (PF-07868489, Placebo for PF-07868489)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • (no location specified)
Nov 14, 2023

Breast Cancer, Ovarian Cancer, Liposarcoma Trial (PF-07224826, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • +5 more
  • (no location specified)
Jun 7, 2023

Healthy Trial in New Haven (PF-07328948, Placebo)

Recruiting
  • Healthy
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Jan 5, 2023

Hemolysis During Pulsed-field and Radiofrequency Ablation

Not yet recruiting
  • Atrial Fibrillation
  • +2 more
  • Pulsed-field ablation
  • Radiofrequency ablation
  • Prague, Czechia
    Cardiocenter, 3rd Medical School, Charles University and Univers
Oct 20, 2023

Healthy Trial (PF-07817883, Itraconazole)

Not yet recruiting
  • Healthy
  • (no location specified)
Apr 10, 2023